5 Recommendations for data collection

5 Recommendations for data collection

5.1 As a condition of the positive recommendation and the managed access agreement, the company is required to collect efficacy data from the KEYNOTE‑052 and KEYNOTE‑361 trials.

  • National Institute for Health and Care Excellence (NICE)